Journal of Affective Disorders
Volume 80, Issue 2 , Pages 285-290 , June 2004

Sensitivity to cholecystokinin-tetrapeptide in major depression

Received 23 December 2002 ,Accepted 8 April 2003.

References 

  1. Akiyoshi J, Isogawa K, Tsutsumi T, Kasturagi S, Kohno K, Furuta M, et al. Cholecystokinin tetrapeptide-induced calcium mobilization in T cells of patients with panic disorder, major depression or schizophrenia. Biol. Psychiatry. 1997;42:151–154
  2. Bradwejn J, Koszycki D. The cholecystokinin hypothesis of anxiety and panic disorders. Ann. NY Acad. Sci. 1994;713:273–282
  3. Brambilla F, Bellodi L, Perna G, Garberi A, Panerai A, Cacerdote P. Lymphocyte cholecystokinin concentrations in panic disorder. Am. J. Psychiatry. 1993;150:1111–1113
  4. Geracioti TD, Nicholson WE, Orth DN, Ekhator NN, Loosen PT. Cholecystokinin in human cerebrospinal fluid: concentrations, dynamics, molecular forms and relationship to fasting and feeding in health, depression and alcoholism. Brain Res. 1993;629:260–268
  5. Gerner RH, Yamada T. Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients. Brain Res. 1982;238:298–302
  6. Kent JM, Papp LA, Martinez JM, Browne ST, Coplan JD, Klein DF, et al. Specificity of panic response to CO2 inhalation in panic disorder: a comparison with major depression and premenstrual dysphoric disorder. Am. J. Psychiatry. 2001;158:58–67
  7. Le Melledo J-M, Merani S, Koszycki D, Bellavance F, Palmour R, Gutkowska J, et al. Sensitivity to CCK-4 in women with and without premenstrual dysphoric disorder (PMDD) during their follicular and luteal phases. Neuropsychopharmacology. 1999;20:81–91
  8. Löfberg C, Agren H, Harro J, Oreland L. Cholecystokinin in CSF from depressed patients. Possible relations to severity of depression and suicidal behavior. Eur. Neuropsychopharmacol. 1998;8:153–157
  9. Lydiard RB, Ballenger J, Laraia M, Fossey MD, Beinfeld MC. CSF cholecystokinin concentrations in patients with panic disorder and normal comparison subjects. Am. J. Psychiatry. 1992;149:691–693
  10. McGrath PJ, Stewart JW, Liebowitz MR, Markowitz JM, Quitkin FM, Klein DF, et al. Lactate provocation of panic attacks in depressed outpatients. Psychiatry Res. 1988;25:41–47
  11. Perna G, Barbini B, Cocchi S, Bertani A, Gasperini M. 35% CO2 challenge in panic and mood disorders. J. Affect. Disord. 1995;33:189–194
  12. Swain J, Koszycki D, Shlik J, Bradwejn J. Pharmacological challenge agents in anxiety. In:  Nutt D,  Ballenger J editor. Anxiety Disorders. Oxford: Blackwell; 2003;p. 269–296
  13. Targum ST. Differential responses to anxiogenic challenge studies in patients with major depressive disorder and panic disorder. Biol. Psychiatry. 1990;28:21–34

PII: S0165-0327(03)00110-1

doi: 10.1016/S0165-0327(03)00110-1

Journal of Affective Disorders
Volume 80, Issue 2 , Pages 285-290 , June 2004

Article Tools